Confocal Laser Endomicroscopy and Optical Coherence Tomography for Diagnosing ILD.
1 other identifier
observational
20
1 country
1
Brief Summary
Often, assessing a classifying diagnosis in patients with interstitial lung disease provides a diagnostic challenge. Currently HRCT, endoscopic or surgical video assisted thoracoscopic surgery(VATS) assessment including lung biopsies are diagnostic tools for patients with suspected ILD. However, tissue acquisition is associated with morbidity in these patients with an already compromised pulmonary function. In clinical practice this results in the fact that only a minor part of patients with an indication for tissue acquisition are actually undergoing biopsies. The aim of this study is to determine ILD-characteristics on imagign collected with minimal invasive novel optical techniques, to examine whether the addition of novel optical techniques to the diagnostic process of ILD could potentially limit the need for a tissue- (surgical) diagnosis and/or reduce the sampling error rate of biopsies by providing additional information on biopsy location.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Oct 2015
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 28, 2015
CompletedFirst Submitted
Initial submission to the registry
January 28, 2016
CompletedFirst Posted
Study publicly available on registry
February 23, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 22, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
April 22, 2017
CompletedSeptember 20, 2017
September 1, 2017
1.5 years
January 28, 2016
September 19, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Describing visual characteristics on CLE-imaging and pOCT imaging of ILD.
cross sectional (1 day)
Secondary Outcomes (5)
(um), size of the alveolar openings, number of cells on CLE imaging of the alveolar space (um).
cross-sectional (1 day)
Size of the alveolar openings (um), thickness of the alveolar septum/alveolar openings on pOCT imaging of the alveolar compartment (um).
cross-sectional (1day)
Feasibility of pOCT alveolar compartment: measuring number of alveoli, trajectory in OCT pull-back with alveoli (mm), number of study-related adverse events.
cross-sectional (1 day)
Correlation between pOCT imaging and histology (alveolar septum-thickness and alveolar space (um))
cross-sectional (1 day)
Correlation between pOCT imaging and histology (alveolar septum thickness (um) and alveolar compartment (mm)
cross-sectional (1 day)
Study Arms (1)
ILD patients
ILD patients scheduled for diagnostic bronchoscopy with biopsy and/or broncho-alveolar lavage will undergo additional imagaing with probe based optical techniques.
Interventions
During the diagnostic bronchoscopy, optical biopsy of the mucosa and alveolar compartment will be conducted by two different probe based optical techniques (Confocal Laser Endomicroscopy (Mauna Kea technologies) and Optical Coherence Tomography (St Jude Medical)). After the study measurements a biopsy will be obtained in the same area.
Eligibility Criteria
Patients of 18 years or older (n=20), who are suspected for ILD based on imaging (HRCT-scan) and with an indication for bronchoscopy with cryobiopsy.
You may qualify if:
- years of age
- Supected ILD and referred for diagnostic bronchoscopic procedure with cryobiopsy
You may not qualify if:
- Smoked in the last 6 months
- Inability and willingness to provide informed consent
- Inability to comply with the study protocol
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Academisch Medisch Centrum
Amsterdam, North Holland, 1105 AZ, Netherlands
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jouke T Annema, MD, PhD
Netherlands, Academisch Medisch Centrum
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- prof.dr. J.T. Annema
Study Record Dates
First Submitted
January 28, 2016
First Posted
February 23, 2016
Study Start
October 28, 2015
Primary Completion
April 22, 2017
Study Completion
April 22, 2017
Last Updated
September 20, 2017
Record last verified: 2017-09
Data Sharing
- IPD Sharing
- Will share
CLE and OCT imaging